Abbreviation	Full Term
ABVD	doxorubicin, bleomycin, vinblastine, and dacarbazine
AVD	doxorubicin, vinblastine, and dacarbazine
BV	brentuximab vedotin
CMR	complete metabolic remission
CMV	Cytomegalovirus
COPP	cyclophosphamide, vincristine, procarbazine, and prednisolone
CT	computed tomography
CTLA4	cytotoxic T-lymphocyte associated protein 4
CVID	Common Variable Immunodeficiency
DHAC	dexamethasone, cytarabine, carboplatin
DHAP	dexamethasone, high-dose cytarabine and cisplatin
EBV	Epstein–Barr virus
EBVD	epirubicin, bleomycin, vinblastine, and dacarbazine
HL	Hodgkin lymphoma
HLH	Hemophagocytic Lymphohistiocytosis
ICON	International Consensus Document
IgA, IgG, IgM	Immunoglobulin A, G, M
IVIG	intravenous immunoglobulin
LMP1/LMP2	latent membrane protein 1/2
LRBA	LPS-responsive beige-like anchor protein
MOPP	mechlorethamine, vincristine, procarbazine, prednisone
NFKB1/2	nuclear factor kappa-light-chain-enhancer of activated B cells 1 and 2
NHL	Non-Hodgkin Lymphoma
PD-1	programmed cell death protein 1
PD-1-i	programmed cell death protein 1 inhibitor
PD-L1/D-L2	programmed cell death-ligand 1/2
PET/CT	positron emission tomography–computed tomography
PIK3CD	phosphatidylinositol-4,5-bisphosphate 3-kinase catalytic subunit delta
PMR	partial metabolic response
RS Cells	Reed–Sternberg Cells
RT	radiation therapy